Tobacco treatment program in an oncologic setting could foster smoking cessation

NewsGuard 100/100 Score

A tobacco treatment program delivered at a cancer center had average seven-day smoking abstinence rates of about 45% at three- and six-month follow-ups and nearly 44% at the nine-month follow-up, and those rates didn't differ between patients with and without cancer.

This observational study included 3,245 participants in a model tobacco treatment program (2,343 with current cancer; 309 with a history of cancer; and 593 with no history of cancer) that consisted of an in-person medical consultation, in-person and telephone counseling sessions, and prescription drug therapy. Limitations of the study include that it wasn't a randomized clinical trial. The findings suggest providing a comprehensive tobacco treatment program in an oncologic setting could foster smoking cessation, which can affect outcomes of patients with cancer who smoke.

Source:
Journal reference:

Cinciripini, P.M. et al. (2019) Association of a Comprehensive Smoking Cessation Program With Smoking Abstinence Among Patients With Cancer. JAMA Network Open. doi.org/10.1001/jamanetworkopen.2019.12251.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Three early-phase clinical studies show promising initial data for patients with lymphoma, gastric cancers